Diabetes Treatments

Diabetes Treatments
DIABETES TREATMENTS
Generic Brand Strength Form Usual
Maintenance
Range
Usual Max Adult Dose
ALPHA-GLUCOSIDASE INHIBITOR
acarbose Precose 25mg, 50mg, 100mg tabs 50−100mg three
times daily
≤60kg: 150mg/day in 3 divided doses
>60kg: 300mg/day in 3 divided doses
miglitol Glyset 25mg, 50mg, 100mg tabs 50mg three times daily 300mg/day in 3 divided doses
AMYLIN ANALOGUE/AMYLINOMIMETIC
pramlintide Symlin 1000mcg/mL SC inj Type 1:
 
30−60mcg
Type 2: 
 
60−120mcg
BIGUANIDE
metformin Fortamet 500mg, 1000mg ext‑rel tabs 2g/day
Glucophage 500mg, 850mg, 1000mg tabs 2.55g/day in 2–3 divided doses
Glucophage XR 500mg, 750mg ext‑rel tabs 2g/day in 1–2 divided doses
Glumetza 500mg, 1000mg ext‑rel tabs 2g/day
Riomet 500mg/5mL oral soln 2.55g/day (25.5mL) in 2–3 divided doses
Riomet ER 500mg/5mL ext-rel oral susp 2g/day (20mL) in 1–2 divided doses
BILE ACID SEQUESTRANT
colesevelam Welchol 625mg tabs 6 tabs once daily or 3 tabs twice daily
Welchol for Oral Suspension 3.75g pwd pkts One 3.75g pkt once daily
DIPEPTIDYL PEPTIDASE-4 INHIBITOR
alogliptin Nesina 6.25mg, 12.5mg, 25mg tabs 25mg once daily
linagliptin Tradjenta 5mg tabs 5mg once daily
saxagliptin Onglyza 2.5mg, 5mg tabs 2.5mg or 5mg once daily
sitagliptin Januvia 25mg, 50mg, 100mg tabs 100mg once daily
DIPEPTIDYL PEPTIDASE-4 INHIBITOR + BIGUANIDE
alogliptin/
metformin
Kazano 12.5mg/500mg, 12.5mg/1000mg tabs 25mg/2000mg per day in divided doses
linagliptin/
metformin
Jentadueto 2.5mg/500mg, 2.5mg/850mg, 2.5mg/1000mg tabs 2.5mg/1000mg twice daily
Jentadueto XR 2.5mg/1000mg, 5mg/1000mg ext-rel tabs 5mg/2000mg daily
saxagliptin/
metformin HCl ext‑rel
Kombiglyze XR 5mg/500mg, 5mg/1000mg, 2.5mg/1000mg ext-rel tabs 5mg/2000mg per day
sitagliptin/
metformin
Janumet 50mg/500mg, 50mg/1000mg tabs 100mg/2000mg per day
Janumet XR 50mg/500mg, 50mg/1000mg, 100mg/1000mg ext‑rel tabs
DIPEPTIDYL PEPTIDASE-4 INHIBITOR + THIAZOLIDINEDIONE
alogliptin/
pioglitazone
Oseni 12.5mg/15mg, 12.5mg/30mg, 12.5mg/45mg, 25mg/15mg, 25mg/30mg, 25mg/45mg tabs 25mg/45mg daily
DOPAMINE RECEPTOR AGONIST
bromocriptine Cycloset 0.8mg tabs 1.6−4.8mg/
 
day
4.8mg/day
 
 
Generic Brand Strength Form Usual
Maintenance
Range
Usual Max Adult Dose
GLINIDE
nateglinide Starlix 60mg, 120mg tabs 120mg 1−30min before meals three times daily 360mg/day in 3 divided doses
repaglinide Prandin 0.5mg, 1mg, 2mg tabs 0.5−4mg within 30min of meals 2−4 times daily 16mg/day
GLINIDE + BIGUANIDE
repaglinide/
metformin
PrandiMet 1mg/500mg,
2mg/500mg
tabs 4mg/1000mg per meal or 10mg/2500mg per day
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST
dulaglutide Trulicity 0.75mg/0.5mL, 1.5mg/0.5mL SC inj 0.75mg−1.5mg once weekly 1.5mg once weekly
exenatide Byetta 250mcg/mL SC inj 5−10mcg twice daily 10mcg twice daily
exenatide ext‑rel Bydureon 2mg SC inj 2mg once every 7 days
liraglutide Victoza 6mg/mL SC inj 1.2−1.8mg/
 
day
lixisenatide Adlyxin 50mcg/mL, 100mcg/mL SC inj 20mcg once daily
semaglutide Ozempic 2mg/1.5mL SC inj 0.5–1mg once weekly 1mg once weekly
Rybelsus 3mg, 7mg, 14mg tabs 7−14mg once daily 14mg once daily
SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR
canagliflozin Invokana 100mg, 300mg tabs 100−300mg once daily 300mg once daily
dapagliflozin Farxiga 5mg, 10mg tabs 5−10mg once daily in AM 10mg once daily
empagliflozin Jardiance 10mg, 25mg tabs 10−25mg once daily 25mg once daily
ertugliflozin Steglatro 5mg, 15mg tabs 5−15mg once daily in AM 15mg once daily
SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR + BIGUANIDE
canagliflozin/
metformin 
HCl
Invokamet 50mg/500mg, 50mg/1000mg, 150mg/500mg, 150mg/1000mg tabs 300mg/2000mg per day
Invokamet XR 50mg/500mg, 50mg/1000mg, 150mg/500mg, 150mg/1000mg ext-rel tabs
dapagliflozin/
metformin HCl ext‑rel
Xigduo XR 2.5mg/1000mg, 5mg/500mg, 5mg/1000mg, 10mg/500mg, 10mg/1000mg ext-rel tabs 10mg/2000mg per day
empagliflozin/
metformin HCl
Synjardy 5mg/500mg, 12.5mg/500mg, 5mg/1000mg, 12.5mg/1000mg tabs 25mg/2000mg per day
Synjardy XR 5mg/1000mg, 10mg/1000mg, 12.5mg/1000mg, 25mg/1000mg ext‑rel tabs
ertugliflozin/
metformin HCl
Segluromet 2.5mg/500mg, 2.5mg/1000mg, 7.5mg/500mg, 7.5mg/1000mg tabs 15mg/2000mg per day
SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITOR + DIPEPTIDYL PEPTIDASE‑4 INHIBITOR
dapagliflozin/
saxagliptin
Qtern 5mg/5mg, 10mg/5mg tabs 10mg/5mg once daily
empagliflozin/
linagliptin
Glyxambi 10mg/5mg, 25mg/5mg tabs 25mg/5mg once daily
ertugliflozin/
sitagliptin
Steglujan 5mg/100mg, 15mg/100mg tabs 15mg/100mg once daily
SULFONYLUREA
chlorpro
pamide

1st generation
100mg, 250mg scored tabs 250−750mg once daily in AM 750mg/day
glimepiride Amaryl 1mg, 2mg, 4mg scored tabs 1−4mg once daily 8mg/day
glipizide
2nd generation
Glucotrol 5mg, 10mg scored tabs 5−15mg once daily or 5−40mg in divided doses 15mg once daily or 40mg in divided doses
Glucotrol 
XL
2.5mg, 5mg, 10mg ext‑rel tabs 5−10mg once daily 20mg/day
glyburide
2nd generation
Diabeta 1.25mg, 2.5mg, 5mg scored tabs 1.25−20mg in single or divided doses 20mg/day in single or divided doses
glyburide, micronized
2nd generation
Glynase PresTab 1.5mg, 3mg, 6mg scored tabs 0.75−12mg in single or divided doses 12mg/day in divided doses
SULFONYLUREA + BIGUANIDE
glipizide/
metformin
2.5mg/250mg,
2.5mg/500mg,
5mg/500mg
tabs 20mg/2000mg per day in single or divided doses
glyburide/
metformin
2.5mg/500mg,
5mg/500mg
tabs 20mg/2000mg per day
THIAZOLIDINEDIONE
pioglitazone Actos 15mg, 30mg, 45mg tabs 15−45mg once daily 45mg once daily
rosiglitazone Avandia 2mg, 4mg tabs 4−8mg in single or 2 divided doses 8mg/day
THIAZOLIDINEDIONE + BIGUANIDE
pioglitazone/
metformin
ACTOplus met 15mg/500mg, 15mg/850mg tabs 45mg/2550mg per day in divided doses
ACTOplus met XR 15mg/1000mg, 30mg/1000mg ext‑rel tabs 45mg/2000mg per day
rosiglitazone/
metformin
1mg/500mg, 2mg/500mg, 4mg/500mg, 2mg/1000mg, 4mg/1000mg tabs 8mg/2000mg per day in divided doses
THIAZOLIDINEDIONE + SULFONYLUREA
pioglitazone/
glimepiride
Duetact 30mg/2mg, 30mg/4mg tabs One 30mg/4mg tab once daily
rosiglitazone/
glimepiride
4mg/1mg, 4mg/2mg, 4mg/4mg, 8mg/2mg, 8mg/4mg tabs 8mg/4mg per day
NOTES

Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. These products are intended for use as part of a total treatment regimen to maintain glycemic control that includes diet, regular exercise, blood glucose monitoring, and glycosylated hemoglobin monitoring. Patients should maintain regular caloric intake.

Adjust dose based on clinical effect. Start at a low dose and gradually titrate upwards according to clinical effect (especially in the elderly, malnourished, debilitated, or those who have renal and/or hepatic dysfunction).

(Rev. 6/2020)